Skip to content
10-Q

Quarterly Report

Evolent Health, Inc. EVH

0001628908-25-000116

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 117.51M sh
Shares Diluted Q2 2025 · Jun 30, 2025 115.88M sh
Shares Diluted Q2 2025 · Jun 30, 2025 115.6M sh
Shares Diluted Q2 2025 · Jun 30, 2024 114.69M sh
Shares Diluted Q2 2025 · Jun 30, 2024 114.42M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$25.77M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $26.33M
Long Term Debt Q2 2025 · Jun 30, 2025 $648.46M
Long Term Debt Q2 2025 · Dec 31, 2024 $490.52M
Short Term Debt Q2 2025 · Jun 30, 2025 $172.12M
Short Term Debt Q2 2025 · Dec 31, 2024 $171.47M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $151M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $104.2M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $101.25M
Stockholders Equity Q2 2025 · Jun 30, 2025 $896.01M
Stockholders Equity Q2 2025 · Mar 31, 2025 $935.52M
Stockholders Equity Q2 2025 · Dec 31, 2024 $1B
Stockholders Equity Q2 2025 · Jun 30, 2024 $1.05B
Stockholders Equity Q2 2025 · Mar 31, 2024 $1.05B
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.07B
Current Liabilities Q2 2025 · Jun 30, 2025 $557.52M
Current Liabilities Q2 2025 · Dec 31, 2024 $715.5M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.34B
Total Liabilities Q2 2025 · Dec 31, 2024 $1.35B
Current Assets Q2 2025 · Jun 30, 2025 $562.26M
Current Assets Q2 2025 · Dec 31, 2024 $607.12M
Total Assets Q2 2025 · Jun 30, 2025 $2.46B
Total Assets Q2 2025 · Dec 31, 2024 $2.54B
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.44
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.07
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.06
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.28
Eps Basic Q2 2025 · Jun 30, 2025 −$0.44
Eps Basic Q2 2025 · Jun 30, 2025 −$1.07
Eps Basic Q2 2025 · Jun 30, 2024 −$0.06
Eps Basic Q2 2025 · Jun 30, 2024 −$0.28
Sga Expense Q2 2025 · Jun 30, 2025 $75.21M
Sga Expense Q2 2025 · Jun 30, 2025 $153.62M
Sga Expense Q2 2025 · Jun 30, 2024 $69.19M
Sga Expense Q2 2025 · Jun 30, 2024 $148.29M
Net Income Q2 2025 · Jun 30, 2025 −$19.9M
Net Income Q2 2025 · Jun 30, 2025 −$84.52M
Net Income Q2 2025 · Jun 30, 2024 $1.6M
Net Income Q2 2025 · Jun 30, 2024 −$15.68M
Operating Income Q2 2025 · Jun 30, 2025 −$1.17M
Operating Income Q2 2025 · Jun 30, 2025 −$2.79M
Operating Income Q2 2025 · Jun 30, 2024 $7.79M
Operating Income Q2 2025 · Jun 30, 2024 −$5.62M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $343.94M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $725.12M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $540.3M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $1.08B
Revenue Q2 2025 · Jun 30, 2025 $444.33M
Revenue Q2 2025 · Jun 30, 2025 $927.98M
Revenue Q2 2025 · Jun 30, 2024 $647.15M
Revenue Q2 2025 · Jun 30, 2024 $1.29B